Agreement on the mutual recognition procedure of registration certificates for medicines

made by Member States of the customs union (Russia, Belarus and Kazkhastan) with GMP, plans to introduce in 2012, 2013.

(firmenpresse) - The Commission of the Custom Unions – Russia, Belarus and Kazakhstan – is currently working on creating new conditions for mutual recognition of registration certificates for medical products in compliance with Good Manufacturing Practice (GMP). "The introduction of the agreement on the mutual recognition procedure of registration certificates for medical products made by Member States of the Customs Union is planned to be introduced in 2012 or 2013", said the deputy of the commission.

On the fifth annual Pharmaceutical Forum Pharma Russia 2011 organized by the newspaper "Vedomosti" on the 11th October 2011 the Director of CU Trade Policy Commission, Ludmila Cheglik, held a speech. And the committee discussed

•The introduction of the rules of good laboratory practices,
•Common rules for inspections on the basis of the existing rules of the international system pharmaceutical inspection,
•Distribution rules and regulations of pharmacy practice.

"In November of this year we will hold the final debate and these rules will be posted for public discussion. Also before the end of the year we will develop and possibly approve the single rule of conformity of production requirements for GMP medicines", stated A. Cheglik.


Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: ChameleonPharma
Datum: 09.11.2011 - 14:55 Uhr
Sprache: Deutsch
News-ID 516629
Anzahl Zeichen: 1432

Kontakt-Informationen:

Kategorie:

Wirtschaft (allg.)

Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 07.11.2011

Diese Pressemitteilung wurde bisher 300 mal aufgerufen.

Die TRIUMPH-Märkte bieten Potenzial für mittelständische OTC- und Pharma-Unternehmen. ...
Gerade auch mittelständische Unternehmen sollten heute international nach Möglichkeiten Ausschau halten, um zusätzliche Marktanteile und Zusatzgewinne zu generieren. Da mit dem Launch in den Emerging Markets große Investitionen und Risiken verbunden sind, ist eine gründliche Marktanalyse ratsam

CHAMELEON PHARMA CONSULTING auf der EXPOPHARM ...
Chameleon Pharama Consulting ist ein junges Unternehmen, das sich aber rasch als zuverlässiger und erfolgreicher Partner für die Markterweiterung im Gesundheitsbereich etabliert hat. 60 erfolgreich abgeschlossene Consulting-Projekte in den letzten drei Jahren – diese Zahlen sprechen für sich.

Polfarma increased its stake in Russian pharma company ...
The joint-stock company Polfarma Pharmaceutical Factory increased its stake in OJSC Integrated Chemical and Pharmaceutical Enterprise Akrikin from 72.54% to 98.17%. Akrikhin is the fifth largest local producer by revenue 2010 and one of the fastest growing pharmaceutical companies on the Russian

Weitere Mitteilungen von Chameleon Pharma Consulting

The EU and Russia agree on mutual recognition of clinical trials ...
"We have to soon sign a document that would address issues concerned the mutual recognition of clinical trials," said the Minister after his meeting with EU Commissioner of Health John Dalli. The goal is: • To regulate standards and practices of clinical research • If products

Ukraine: No limit for drug and OTC advertising ...
According to news.liga.net, the project planned to allow the placement of advertising and distribution of drugs only • In specialized publications intended for medical facilities and doctors. • By placing advertisements in medical institutions and pharmacies. • And also proposed to exten

Compared to 2011 the purchase of drugs in 2012 via the program “7 nostages” will increase by 13% ...
Compared to 2011 in 2012 the purchase of drugs for treatments like hematopoietic and related tissues, hemophilia, multiple sclerosis, as well as post-transplant organs and other tissues, will increase by 13%. •The budget allocation for these purposes in 2012 - 2014 will amount up to 54.17 billi

In Kazakhstan, the birth rate increased by 25% ...
The “National Research Medical Centre” has successfully implemented a program of health development. Because: • Of the increased birth rate of 25% • The mortality reduction of 11% • And increased life expectancy by more than 2 years. I am sure that the international congress will g